Literature DB >> 26883955

Design of pH-Responsive Biomaterials to Enable the Oral Route of Hematological Factor IX.

Sarena D Horava1,2, Nicholas A Peppas3,4,5,6,7.   

Abstract

The oral administration of hematological factor IX (FIX) can offer a convenient prophylactic treatment for hemophilia B patients. pH-Responsive hydrogels based on poly(methacrylic acid)-grafted-poly(ethylene glycol) (P(MAA-g-EG)) have been engineered as delivery vehicles for FIX. In oral delivery, such hydrogel carriers protected FIX from the gastric environment and released it under intestinal conditions as demonstrated by evaluation of the loading and release of FIX. Tailoring of the hydrogel networks improved the loading of FIX within the microcarriers, which is critical for minimizing protein degradation. Optimizing the loading conditions by increasing the incubation time and using a reduced ionic strength buffer further improved the delivery potential of the microcarriers. The presence of the microcarriers significantly enhanced the oral absorption of FIX in vitro. As shown in this work, P(MAA-g-EG) microcarriers are promising candidates for the oral delivery of FIX.

Entities:  

Keywords:  Biomaterials; Drug delivery; Factor IX; Hydrogels

Mesh:

Substances:

Year:  2016        PMID: 26883955      PMCID: PMC4880530          DOI: 10.1007/s10439-016-1566-x

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  19 in total

1.  Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.

Authors:  G C White; F Rosendaal; L M Aledort; J M Lusher; C Rothschild; J Ingerslev
Journal:  Thromb Haemost       Date:  2001-03       Impact factor: 5.249

2.  Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.

Authors:  Mariko Morishita; Takahiro Goto; Koji Nakamura; Anthony M Lowman; Kozo Takayama; Nicholas A Peppas
Journal:  J Control Release       Date:  2005-12-02       Impact factor: 9.776

3.  pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins.

Authors:  Michael C Koetting; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2014-05-20       Impact factor: 5.875

4.  Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice.

Authors:  Dheeraj Verma; Babak Moghimi; Paul A LoDuca; Harminder D Singh; Brad E Hoffman; Roland W Herzog; Henry Daniell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 5.  Therapeutic applications of hydrogels in oral drug delivery.

Authors:  Lindsey A Sharpe; Adam M Daily; Sarena D Horava; Nicholas A Peppas
Journal:  Expert Opin Drug Deliv       Date:  2014-06       Impact factor: 6.648

6.  Oral delivery of insulin using pH-responsive complexation gels.

Authors:  A M Lowman; M Morishita; M Kajita; T Nagai; N A Peppas
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

7.  Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up.

Authors:  Maria Elisa Mancuso; Luisa Berardinelli; Claudio Beretta; Mauro Raiteri; Ermanno Pozzoli; Elena Santagostino
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

8.  Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.

Authors:  Noriyasu Kamei; Mariko Morishita; Hitomi Chiba; Nikhil J Kavimandan; Nicholas A Peppas; Kozo Takayama
Journal:  J Control Release       Date:  2008-11-27       Impact factor: 9.776

9.  The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models.

Authors:  Kristy M Wood; Gregory M Stone; Nicholas A Peppas
Journal:  Acta Biomater       Date:  2009-05-28       Impact factor: 8.947

10.  Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

Authors:  Sarah C Darby; Sau Wan Kan; Rosemary J Spooner; Paul L F Giangrande; Frank G H Hill; Charles R M Hay; Christine A Lee; Christopher A Ludlam; Michael Williams
Journal:  Blood       Date:  2007-04-19       Impact factor: 22.113

View more
  3 in total

Review 1.  Recent advances in hemophilia B therapy.

Authors:  Sarena D Horava; Nicholas A Peppas
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

2.  Modular Fabrication of Intelligent Material-Tissue Interfaces for Bioinspired and Biomimetic Devices.

Authors:  John R Clegg; Angela M Wagner; Su Ryon Shin; Shabir Hassan; Ali Khademhosseini; Nicholas A Peppas
Journal:  Prog Mater Sci       Date:  2019-07-17

Review 3.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.

Authors:  Angela M Wagner; Margaret P Gran; Nicholas A Peppas
Journal:  Acta Pharm Sin B       Date:  2018-03-02       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.